MAARSSEN, Netherlands - CPhI Japan - with ICSE Japan and P-MEC Japan - marked its seventh anniversary in April with robust numbers and positive feedback, against the most challenging business background in pharma services for several years.
Organisers UBM International Media were rewarded with good exhibitor and visitor responses to expanded and new features. The co-located events form Japan’s leading ingredients, contract services and equipment exhibitions and seminars.
Bookings for next year’s Japan shows were also higher than in previous years. In a further positive development for the region, this month’s CPhI China exhibition has been fully sold, with visitor pre-registrations sharply ahead of 2008.
In total, the events and seminar programmes at Tokyo’s Big Sight on 21 - 23 April attracted nearly 14,000 attendees, hosted by 445 exhibitors from 27 countries. Attendance was therefore higher than last year.
Reflecting the increased convergence of pharma and biotech business models, the debut BioPharma Pavilion attracted positive exhibitor feedback on visitor numbers, focus and quality.
Keynote and special seminars hosted by government, industry organisations and manufacturers were notably popular - with the 130+ seminar programme being significantly bigger than last year. Over 700 attendees were recorded for the Japanese pharmaceutical industry speakers on the second day.
Eliane van Doorn, UBM International Media’s Group Director for Pharma Ingredients events, commented: “This year’s expanded seminar programme and BioPharma Pavilion debut both helped event attendance to higher numbers than last year”.
And she continued: “Most notable is the achievement of significant gains against the background of a very challenging business climate in pharma services. Feedback strongly confirms that both exhibitors and visitors are placing more value on the networking and professional/technical meetings that underpin the business value and reputation of CPhI Japan and its co-located events”.
The re-booking rate for 2010 - already including the China and Korea pavilions - was above that of 2008 for 2009, and higher than expected given the business climate.
Formal supporters of the three events include Japan’s Ministry of Health, Labour and Welfare, the Ministry of Economy, Trade and Industry and 17 trade associations and industry organisations.
CPhI Japan, ICSE Japan and P-MEC Japan are staged by UBM International Media and sister company CMP Business Media Co. Ltd. Japan. Co-organizers are The Chemical Daily Co. Ltd. - publishers of The Chemical Daily and Japan Chemical Week.
The 2010 exhibitions will again be at Big Sight - and on the same dates as this year, 21 - 23 April.
This month’s CPhI China, with ICSE China and P-MEC China, takes place in Shanghai on 23 - 25 June. The exhibitions and CPhI China International Forum form Asia’s largest networking event for the pharma services sector. By early May, visitor pre-registrations were 30% ahead of the comparable figures in 2008.
Notes for Editors: - UBM International Media operates market-leading global exhibition brands and their complementary media products. - The CPhI pharmaceutical ingredients and related sector exhibitions currently number over 12 highly-regarded annual events. The portfolio also includes Informex (speciality chemicals), Food Ingredients, HBA (health & beauty industry) and Sea Trade (cruise industry). - Worldwide locations for its events include China, India, Japan, North America, Brazil, Africa and Europe. More than 330,000 business professionals and marketers visit UBM exhibitions each year. - The exhibitions portfolio is managed from Holland. UBM International Media has approximately 1,200 employees in the UK, US, Asia and Europe. See www.ubm.com Media Enquiries: Rob Sahi (CPhI) UBM International Media Tel: + 31 (0)346-559-461 Ian O’Malley (ICSE, P-MEC, BioPH) UBM International Media Tel: +31 (0)346-559-426 Roger Johnstone GyroHSR PR Tel: +44 (0)161-614-1450
Source: UBM International Media
Rob Sahi (CPhI), +31 (0)346-559-461, or Ian O’Malley (ICSE, P-MEC, BioPH), +31 (0)346-559-426, both of UBM International Media; or Roger Johnstone, GyroHSR PR, +44 (0)161-614-1450
Related Press Releases
HRA Pharma Launches ellaOne(R) in EuropeSeptember 30th, 2009 PARIS -
- New Generation Emergency Contraception now Commercially Available in France, Germany and the United Kingdom, in Anticipation of Upcoming Launch Throughout European Union
HRA Pharma (www.hra-pharma.com), a privately-held, European pharmaceutical company that designs products, devices and supporting services in reproductive health and endocrinology, announced today that ellaOne(R) (ulipristal acetate, 30mg), its new generation emergency contraceptive, has been launched in France, Germany and the United Kingdom via local HRA teams. HRA Pharma will progressively launch ellaOne in all European countries over the coming months.
Dutch Top Institute Pharma Attracts International InterestSeptember 9th, 2009 LEIDEN, The Netherlands - The Danish Council for Strategic Research is visiting the Dutch Top Institute Pharma (TI Pharma) on Thursday, September 10. The purpose of their visit is to learn about the unique Dutch approach on public-private cooperation and the concrete results that are being booked by this institute.
Sao Paulo Hosts Second CPhI and P-MEC South America Pharma EventsAugust 5th, 2009 MAARSSEN, Netherlands -
Against the background of continuing strong market growth, Sao Paulo will host the second CPhI South America and P-MEC South America pharma ingredients and production technology events on Wednesday 26 - Friday 28 August. Staged by UBM International Media, the debut events in Rio last August welcomed over 180 exhibitors and nearly 4,500 attendees.
China Pharma Events Keep Growing For UBMAugust 5th, 2009 MAARSSEN, Netherlands -
Numbers were impressive at June's CPhI China, with ICSE China and P-MEC China - which together form Asia's biggest annual networking opportunity for the pharma ingredients, services and production equipment communities. Staged by UBM at Shanghai's New International Expo Centre on 23 - 25 June, the combined events hosted 1,651 exhibitors from 17 countries and welcomed nearly 23,700 visits.
"Over the Next 2-3 Years We Will Leverage Developmental Capabilities and Explore In-licensing and a Co-development Model to Consolidate Our Presence in Japan" - Dr. Kailash Sharma, President, Japan Operations, Zydus CadilaJuly 29th, 2009 TOKYO - With a business plan to launch 8-10 new products each year, Nippon Universal Pharmaceutical Co. Ltd., a subsidiary of the Zydus group, one of India's leading integrated pharma companies & a global healthcare provider, is looking to give a big boost to its operations in the Japanese generic market which is still evolving.
Paris Dates for CPhI Worldwide 2010June 14th, 2009 MAARSSEN, Netherlands - CPhI Worldwide returns to Paris for 2010 when, with ICSE, PMEC and BioPh, the world's leading pharma services industry event will be staged at Paris-Nord Villepinte on Tuesday 5 - Thursday 7 October. This is a week earlier than the 2009 event in Madrid, but close to the dates of the last staging in Paris, in 2006.
HRA Pharma Granted European Marketing Authorization for ellaOne(R)May 25th, 2009 PARIS - Next Generation Emergency Contraceptive Will First be Launched in UK, Germany and France as Company Expands International Operations
HRA Pharma (www.hra-pharma.com), a privately-held, European pharmaceutical company that designs products, devices and supporting services in reproductive health and endocrinology, announced today that ellaOne(R) (ulipristal acetate), its next generation emergency contraceptive, has been granted marketing authorization by the European Commission. The unanimous decision by all member states enables HRA Pharma to begin marketing ellaOne throughout the European Union, making it the only approved product to have been specifically designed and developed for use as an emergency contraceptive.
Teikoku Pharma USA Acquires Travanti Pharma Inc.May 7th, 2009 SAN JOSE, California - Teikoku Pharma USA Inc., the international specialty pharmaceutical company today announced that it has acquired effective May 8, 2009; Minneapolis area based Travanti Pharma Inc., a privately held corporation that designs, develops and markets innovative drug delivery platforms that improve the safety, compliance, effectiveness and ease of administration of medications delivered to the body. The Company has developed a proprietary Wearable Electronic Disposable Drug delivery technology (WEDD(R)) Platform.
BioCis Pharma Starts Phase IIa Trial in PsoriasisMarch 11th, 2009 TURKU, Finland - BioCis Pharma Ltd., a privately-held drug development company with its
headquarters in Turku, Finland, announced that it has begun a new Phase IIa
clinical testing of ProtoCure(TM) emulsion cream, the company's novel topical
drug for dermatology. The double-blind, vehicle-controlled study is designed
to evaluate the tolerability, pharmacokinetics, and efficacy of the topical
product in a total of 18 subjects with mild to moderate plaque psoriasis.
Thomson Reuters Publishes Pharma Matters White Paper, 'The Five Myths of Generic Competition'March 10th, 2009 PHILADELPHIA and LONDON - Unique Survey Shows Much Room for Originator Pharmaceutical Companies
to Improve Their Understanding of Generic Competition
The Healthcare and Science business of Thomson Reuters today released the
white paper, "The Five Myths of Generic Competition," highlighting what
originator pharmaceutical and biotech companies can do to improve their
forecasting of the likely timing, source and intensity of competition from
generic drugs. The findings in this white paper are based on an independent survey of
commercial professionals in pharmaceutical and biotech companies.
Related News
Dainippon Sumitomo Pharma of Japan acquiring US drug maker Sepracor for $2.6 billionSeptember 3rd, 2009 Dainippon of Japan acquires US drug maker SepracorTOKYO — Japanese drug company Dainippon Sumitomo Pharma Co. is acquiring U.S.
US trade envoy says US makes progress toward opening Japanese marketJuly 6th, 2009 US, Japan make progress on opening Japanese marketWASHINGTON — The United States says it has made progress in opening Japan's market to foreign investors. The U.S. trade envoy's office said Monday in an 86-page report that the countries were acting to speed up regulatory reviews for pharmaceuticals and medical devices.
Calendar of major business events scheduled for FridayApril 23rd, 2009 Major business events scheduled for FridayMajor business events and economic events scheduled for Friday:
WASHINGTON — Labor Department releases employment data for September, 8:30 a.m. WASHINGTON — Commerce Department releases factory orders for August, 10 a.m.
Bry-Air mulls acquisition in JapanSeptember 7th, 2009 CHENNAI - Dehumidifier manufacturer Bry-Air (Asia) is looking to expand its Asian footprint by acquiring companies in Japan. "We have been exporting to Japan in small numbers, now we have decided to attack the $30 million market there.
Emami to demerge realty, Zandu Pharma unitJune 19th, 2009 MUMBAI - The boards of Emami and Zandu Pharma have approved hiving off Emami's realty business into a separate firm, and merging Zandu's consumer goods (FMCG) unit with Emami, the companies said Friday. "The realty business of Emami will be now a separate company, Emami Infrastructure Ltd," Emami said in regulatory statement.
Four Gujarat pharma units found stashing used syringesMarch 6th, 2009 AHMEDABAD - In what could be termed an eye opener for other pollution control bodies across India, the Gujarat Pollution Control Board (GPCB) has so far found four pharmaceutical units near here storing used syringes and needles in their warehouses. Board officials raided the factories Thursday afternoon after being told by the Ahmedabad Municipal Corporation (AMC) about the possibility of the four pharma units in Naroda, Narol and Isanpur storing used syringes and needles.
Anil Ambani group firms among top stock performersMay 25th, 2009 MUMBAI - Three companies in the Reliance Anil Dhirubhai Ambani Group were among the five top-performing stocks of the S&P CNX Nifty of the National Stock Exchange (NSE) last week, all of them outshining the 50-share index by a wide margin. With a gain of 52.7 percent, Reliance Capital was the best performer among the Nifty stocks.
Burger King woos McDonald's-dominated Japan with hot Angry WhopperJuly 22nd, 2009 Burger King woos Japan with 'angry' burgerTOKYO — The Angry Whopper is arriving in Japan, a nation where the competition over hamburgers is as sizzling hot as the new spicy offering from U.S. fast-food chain Burger King.
Japan auto production falls in May for 8th straight month of declinesJune 29th, 2009 Japan auto production falls for 8th straight monthTOKYO — Japan's auto production fell for the eighth straight month in May, plummeting 41.4 percent from a year earlier, as the nation's top industry continued to be hammered by the global slowdown. Japan produced 542,282 vehicles in May, the Japan Automobile Manufacturers Association said Monday in a monthly report.
Calendar of major business events and economic reports scheduled for TuesdayMay 4th, 2009 Business events scheduled for TuesdayMajor business events and economic events scheduled for Tuesday:
WASHINGTON — Labor Department releases productivity for the second quarter, 8:30 a.m. EDT. WASHINGTON — Commerce Department releases wholesale trade inventories for June, 10 a.m.
